Basilea Pharmaceutica
BSLN.SW
#6387
Rank
A$0.93 B
Marketcap
$77.38
Share price
-5.97%
Change (1 day)
20.17%
Change (1 year)

Earnings for Basilea Pharmaceutica (BSLN.SW)

Earnings in 2023: A$20.45 Million

According to Basilea Pharmaceutica's latest financial reports the company's current earnings are A$0.18 Billion. In 2023 the company made an earning of A$20.45 Million a decrease over its 2022 earnings that were of A$21.53 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Basilea Pharmaceutica from 2002 to 2023

Annual earnings

Year Earnings Change
2023A$20.45 M-5.02%
2022A$21.53 M-276.18%
2021-A$12.23 Million-55.31%
2020-A$27.36 Million-28%
2019-A$37.99 Million-27.06%
2018-A$52.09 Million62.13%
2017-A$32.13 Million-60.94%
2016-A$82.24 Million-19.67%
2015-A$0.11 Billion48.25%
2014-A$69.06 Million12.95%
2013-A$61.14 Million-35.16%
2012-A$94.3 Million-5.75%
2011-A$0.11 Billion-152.57%
2010A$0.19 B-199.59%
2009-A$0.2 Billion-15.54%
2008-A$0.23 Billion22.84%
2007-A$0.19 Billion60.07%
2006-A$0.12 Billion85.69%
2005-A$61.98 Million-43.04%
2004-A$0.11 Billion47.04%
2003-A$73.99 Million-32.52%
2002-A$0.11 Billion